Explore Publications

Three Barclays bankers made more than $15 million in 2011 salary packages, with the CEO making $28 million. The numbers were revealed under a pact made by the banking sector with the UK government, under Project Merlin, sparking outrage.

Greg Smith, a Goldman Sachs employee in London, has quit the company with a fiercely critical op-ed in the New York Times in which he accuses the Wall Street investment bank of losing its moral compass.

The World Trade Organization ruled that U.S. planemaker Boeing received $5.3 billion in illegal government subsidies over a quarter-century. Airbus and Boeing have both complained to the WTO that the other is receiving state aid. They are locked in a long-running trade dispute over a market believed to be worth more than $3 trillion over the next decade.

Two Spanish lawyers have launched a campaign on social networking sites to prise out information about Euribor, the reference interest rate used for calculating mortgage payments in Spain, and to draw attention to the lack of transparency surrounding the way the rate is set.

During the final, desperate days before it entered bankruptcy proceedings, MF Global executives took money from segregated customer accounts - money that belonged not to MF Global but to the farmers and commodities traders that were its clients - and used it to prop up its rapidly collapsing business. Nor was this petty cash: of the $6.9 billion in customer assets that MF Global held, a stunning $1.6 billion is missing. There is virtually no chance that the full amount will ever be recovered.

GlaxoSmithKline boss Sir Andrew Witty's pay package more than doubled to £6.7m last year - but the drugs group reckons he remains underpaid and has awarded him a new deal which could generate up to £10.4m this year.

The decision by PH Kurian, the controller general of patents, designs and trademarks in India, to allow a local company to manufacture Sorafenib, a drug used to treat advanced kidney cancer and liver cancer, is a welcome move that supports the access of poor people to cheap life-saving drugs.

Mahmoud Karzai, brother to the Afghan president and Abdul Hasin Fahim, brother to the vice-president, are the real symbols of corruption in Afghanistan. Kabul Bank has helped finance their shady deals and contracts with the U.S. military

The European Food Safety Authority has approved new rules that will ban industry experts from serving on EFSA scientific panels related to their work. Corporate Europe Observatory says the rules are still not strong enough

A Swiss drug company, Novartis, will go before the Indian Supreme Court this monnth to fight patent laws that protect the global supply of inexpensive medicines to treat AIDS, cancer and other diseases. The lawsuit - which involves a drug called Gleevec - is being opposed by international aid groups.